Xeris Pharmaceuticals Inc (XERS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Sales | 297 | 248 | 759 | 582 | 819 |
| Gross Profit | 297 | 248 | 801 | 582 | 819 |
| Operating Expenses | 34,357 | 25,685 | 21,073 | 15,525 | 13,176 |
| Operating Income | -34,060 | -25,437 | -20,314 | -14,943 | -12,357 |
| Interest Expense | 1,062 | 1,063 | 1,055 | 737 | 562 |
| Other Income | 737 | 1,223 | 950 | 913 | -68 |
| Pre-tax Income | -34,385 | -25,277 | -20,419 | -14,767 | -12,987 |
| Net Income Continuous | -34,385 | -25,277 | -20,419 | -14,767 | -12,987 |
| Net Income | $-34,385 | $-25,277 | $-20,419 | $-14,767 | $-12,987 |
| EPS Basic Total Ops | -1.28 | -1.07 | 4.28 | -0.71 | -3.07 |
| EPS Basic Continuous Ops | -1.28 | -1.07 | 4.28 | -0.71 | -3.07 |
| EPS Diluted Total Ops | -1.28 | -1.07 | 4.28 | -0.71 | -3.07 |
| EPS Diluted Continuous Ops | -1.28 | -1.07 | 4.28 | -0.71 | -3.07 |
| EBITDA(a) | $-33,573 | $-25,052 | $-19,892 | $-14,782 | $-12,163 |